These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18557968)

  • 21. The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour.
    Bradford JM
    Can J Psychiatry; 2001 Feb; 46(1):26-34. PubMed ID: 11221487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological treatment of patients with paraphilic disorders and risk of sexual offending: An international perspective.
    Turner D; Petermann J; Harrison K; Krueger R; Briken P
    World J Biol Psychiatry; 2019 Oct; 20(8):616-625. PubMed ID: 29057702
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychological interventions for adults who have sexually offended or are at risk of offending.
    Dennis JA; Khan O; Ferriter M; Huband N; Powney MJ; Duggan C
    Cochrane Database Syst Rev; 2012 Dec; 12():CD007507. PubMed ID: 23235646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological treatment of sexual offenders in German outpatient treatment centers.
    Turner D; Gregório Hertz P; Sauter J; Briken P; Rettenberger M
    Int Clin Psychopharmacol; 2018 Nov; 33(6):349-352. PubMed ID: 29738426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists.
    Briken P; Nika E; Berner W
    J Sex Marital Ther; 2001; 27(1):45-55. PubMed ID: 11224953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey on the Prescription Patterns of Pharmacological Agents in Individuals Who Have Committed Sexual Offenses During Forensic Outpatient Treatment in Germany: How Many Discontinue Testosterone Lowering Medication Under Parole?
    Sauter J; Rettenberger M; Briken P; Turner D
    J Sex Med; 2022 Jul; 19(7):1147-1155. PubMed ID: 35624071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions.
    Deutsch SI; Burket JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110017. PubMed ID: 32544599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy of sexual offenders.
    Richer M; Crismon ML
    Ann Pharmacother; 1993 Mar; 27(3):316-20. PubMed ID: 8453171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antilibidinal drugs and mental retardation: a review.
    Clarke DJ
    Med Sci Law; 1989 Apr; 29(2):136-46. PubMed ID: 2526280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Issues to consider in the assessment and treatment of paraphilic patients.
    Saleh FM
    J Clin Psychiatry; 2005 Jun; 66(6):802-3; author reply 803. PubMed ID: 15960581
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacotherapy of pervasive developmental disorders in children and adolescents.
    Masi G
    CNS Drugs; 2004; 18(14):1031-52. PubMed ID: 15584771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: a case series.
    Kafka MP; Hennen J
    J Clin Psychiatry; 2000 Sep; 61(9):664-70. PubMed ID: 11030487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disorders of sexual impulse control in neuropsychiatric conditions.
    Krueger RB; Kaplan MS
    Semin Clin Neuropsychiatry; 2000 Oct; 5(4):266-74. PubMed ID: 11291023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychological interventions for those who have sexually offended or are at risk of offending.
    Kenworthy T; Adams CE; Bilby C; Brooks-Gordon B; Fenton M
    Cochrane Database Syst Rev; 2004; (3):CD004858. PubMed ID: 15266545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WITHDRAWN: Psychological interventions for those who have sexually offended or are at risk of offending.
    Kenworthy T; Adams CE; Bilby C; Brooks-Gordon B; Fenton M
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD004858. PubMed ID: 18843670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Learning from research: Adapting interventions for sexual offending to improve outcomes.
    Völlm B; Craissati J; Grubin D; Skett S; Williams F
    Crim Behav Ment Health; 2019 Aug; 29(4):227-238. PubMed ID: 31478289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polypharmacy in the treatment of subjects with intellectual disability.
    Häβler F; Thome J; Reis O
    J Neural Transm (Vienna); 2015 Aug; 122 Suppl 1():S93-100. PubMed ID: 24858727
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.